These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
    Author: Li AJ, McAllister P, Karlan BY.
    Journal: Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997.
    Abstract:
    PURPOSE: Androgen signaling may function in the pathobiology of epithelial ovarian cancers associated with mutations in the BRCA1/2 genes. Androgen receptor (AR) activity correlates inversely with length of a polymorphic cytosine-adenine-guanine (CAG) repeat in exon 1. We hypothesized that AR CAG allele length is a modifier of clinical outcome in BRCA1/2 mutation positive women with ovarian cancer. EXPERIMENTAL DESIGN: We identified BRCA1/2 ovarian cancer patients with banked serum from which we PCR amplified the CAG repeat region. We abstracted clinical and survival data, and examined CAG repeat length <19 as a short AR allelotype. We calculated a sample size of 60 patients to determine a 24-month difference in survival. RESULT: In 62 patients, 43 (69%) had BRCA1 mutations and 19 (31%) had BRCA2 mutations. Fifteen (24%) were found to have a short AR allelotype. Patients with a short AR did not demonstrate statistical differences in progression-free survival (43 months vs. 28 months for long AR) or overall survival (78 months vs. 142 months for long AR). In patients with BRCA2 mutations alone, a short AR correlated with decreased overall survival (31 months) compared to 126 months for those with a long AR (p=0.01). CONCLUSIONS: AR allelotype length did not correlate with survival in this statistically representative cohort of patients with BRCA1/2 mutations. Potential associations between short AR and outcome in BRCA2-associated ovarian cancers remain to be determined.
    [Abstract] [Full Text] [Related] [New Search]